$1.38
0.010.73%
Nanoviricides (NNVC) earnings history, EPS estimates, revenue forecasts and company guidance.
Earnings Per Share (Non-GAAP)
Quarterly Revenue (Billions)
| Metric | Q4 '26 | Q3 '26 | Q2 '26 | Q1 '26 |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Estimate | $-0.09 | $-0.09 | $-0.10 | $-0.16 |
| Actual | $-0.10 | $-0.09 | $-0.11 | $-0.10 |
| Surprise | -11.1% | 0.00% | -10.0% | +37.5% |
| Revenue | ||||
| Estimate | — | — | — | — |
| Actual | $0 | $0 | $0 | $0 |
| Surprise | — | — | — | — |
| Metric | Q1 '27E | Q2 '27E | Q3 '27E | Q4 '27E |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Consensus | $-0.09 | $-0.09 | $-0.12 | $-0.13 |
| Revenue | ||||
| Consensus | — | — | — | — |
| Trimestre fiscale | Data segnalata | EPS effettivo | EPS stimato | Sorpresa% |
|---|---|---|---|---|
| Q4 | Sep 28, 2026 | $-0.10 | $-0.09 | -11.1 % |
| Q3 | May 15, 2026 | $-0.09 | $-0.09 | 0.00 % |
| Q2 | Feb 17, 2026 | $-0.11 | $-0.10 | -10.0 % |
| Q1 | Nov 14, 2025 | $-0.10 | $-0.16 | 37.5 % |